Related Experiment Video
Updated: Sep 6, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1
1Department of Radiation Oncology, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an No. 2 Hospital, Jiangsu, China. zlq_hill@126.com.
Objective:
Gastric cancer (GC) is the fourth common cancer worldwide. Long non-coding RNA TOB1 antisense RNA 1 (TOB1-AS1) has been found to participate in the process of GC, while the precise role of TOB1-AS1 is still not understood in GC progression.
Materials And Methods:
We collected 21-paired GC and para-carcinoma tissue specimens, and the levels of TOB1-AS1 and lysosomal sialidase (NEU1) were detected by quantitative Real-Time Polymerase Chain Reaction (qRT-PCR). The protein expression levels of NEU1, b-catenin, c-Myc, Cyclin D1, N-cadherin were determined via Western blot. Cell proliferation was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Flow cytometry was performed to evaluate cell proliferation. Besides, GC cell migration and invasion capacities were identified by transwell assay. Dual-Luciferase reporter assay was employed to examine the interrelation between miR-23a and TOB1-AS1 or NEU1. Finally, the role of TOB1-AS1 was verified in vivo.
Results:
The levels of TOB1-AS1 were decreased in GC tissues and cell lines. Either TOB1-AS1 or NEU1 upregulation accelerated GC cell apoptosis, hampered proliferation, migration, and invasion. Further, the role of TOB1-AS1 silencing on cell behaviors was abrogated by NEU1 upregulation. TOB1-AS1 and NEU1 exerted their roles via Wnt/b-catenin signaling pathway. Overexpression of TOB1-AS1 blocked GC development in vivo. Mechanically, miR-23a was targeted by TOB1-AS1, but directly targeted NEU1.
Conclusions:
TOB1-AS1/miR-23a/NEU1 axis regulated proliferation, apoptosis, migration, and invasion of GC cells via Wnt/b-catenin pathway, providing the evidence for serving TOB1-AS1 as an underlying therapeutic target in human GC treatment.
Insights
Long non-coding RNA TOB1 antisense RNA 1 (TOB1-AS1) is downregulated in gastric cancer (GC). Upregulating TOB1-AS1 or NEU1 inhibits GC progression by targeting miR-23a via the Wnt/β-catenin pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer (GC) is a significant global health challenge.
- The role of long non-coding RNA TOB1 antisense RNA 1 (TOB1-AS1) in GC progression remains unclear.
Purpose of the Study:
- To elucidate the precise role of TOB1-AS1 in gastric cancer.
- To investigate the molecular mechanisms underlying TOB1-AS1's function in GC.
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) and Western blot to assess gene and protein expression.
- Cellular assays including MTT, flow cytometry, and Transwell assays to evaluate proliferation, apoptosis, migration, and invasion.
- Dual-Luciferase reporter assay to determine interactions between TOB1-AS1, miR-23a, and NEU1, with in vivo validation.
Main Results:
- TOB1-AS1 levels were significantly decreased in GC tissues and cell lines.
- Upregulation of TOB1-AS1 or lysosomal sialidase (NEU1) inhibited GC cell proliferation, migration, and invasion while promoting apoptosis.
- TOB1-AS1 acts as a sponge for miR-23a, which in turn targets NEU1, collectively regulating the Wnt/β-catenin signaling pathway.
Conclusions:
- The TOB1-AS1/miR-23a/NEU1 axis plays a crucial role in regulating GC cell proliferation, apoptosis, migration, and invasion via the Wnt/β-catenin pathway.
- TOB1-AS1 demonstrates potential as a therapeutic target for human gastric cancer.
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways
MicroRNAs
